一项评估并优化抗血小板药物在普通外科和腹部外科手术围手术期管理中使用的随机对照试验——APAP试验（国际标准随机对照试验编号：ISRCTN45810007）

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

作者信息

Antolovic Dalibor, Reissfelder Christoph, Rakow Anastasia, Contin Pietro, Rahbari Nuh N, Büchler Markus W, Weitz Jürgen, Koch Moritz

机构信息

Department of Surgery, University of Heidelberg, Germany.

出版信息

BMC Surg. 2011 Mar 3;11:7. doi: 10.1186/1471-2482-11-7.

DOI:10.1186/1471-2482-11-7

PMID:21371292

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3056734/

Abstract

BACKGROUND

Due to the increase of cardiovascular diseases acetylsalicylic acid (ASA) has become one of the most frequently prescribed drugs these days. Despite the rising number of patients with ASA medication presenting for elective general and abdominal surgery and the potentially increased risk of hemorrhage in these patients, there are no clear, evidence-based guidelines for the perioperative use of antiplatelet agents. The present randomised controlled trial was designed to evaluate the safety and optimize the use of ASA in the perioperative management of patients undergoing general and abdominal surgery.

METHODS/DESIGN: This is a two-arm, monocenter randomised controlled trial. Patients scheduled for elective surgical treatment (i.e. inguinal hernia repair, cholecystectomy and colorectal resections) with ASA as a permanent medication are randomised equally to perioperative continuation or discontinuation of ASA. Patients who are randomised in the discontinuation group stop the administration of ASA five days prior to surgical treatment and start intake of ASA on postoperative day 5. Fifty-two patients will be enrolled in this trial. The primary outcome is the incidence of postoperative bleeding and cardiovascular events at 30 days after surgery. In addition a set of general as well as surgical variables are analysed.

DISCUSSION

This is a randomised controlled two-group parallel trial designed to assess the safety and optimize the use of ASA in the perioperative management of patients undergoing general and abdominal surgery. The results of this pilot study build the basis for a confirmative randomised controlled trial that may help to clarify the use and potential risk/benefits of perioperative ASA medication in patients undergoing elective surgery.

TRIAL REGISTRATION

The trial is registered with Current Controlled Trials ISRCTN45810007.

摘要

背景

由于心血管疾病的增加，乙酰水杨酸（ASA）如今已成为最常用的处方药之一。尽管服用ASA进行择期普通外科和腹部手术的患者数量不断增加，且这些患者出血风险可能增加，但目前尚无关于围手术期使用抗血小板药物的明确、循证指南。本随机对照试验旨在评估ASA在接受普通外科和腹部手术患者围手术期管理中的安全性，并优化其使用。

方法/设计：这是一项双臂、单中心随机对照试验。计划接受择期手术治疗（即腹股沟疝修补术、胆囊切除术和结直肠切除术）且长期服用ASA的患者被随机分为围手术期继续或停用ASA两组。随机分入停药组的患者在手术治疗前5天停止服用ASA，并在术后第5天重新开始服用。本试验将招募52名患者。主要结局是术后30天出血和心血管事件的发生率。此外，还将分析一系列一般和手术变量。

讨论

这是一项随机对照两组平行试验，旨在评估ASA在接受普通外科和腹部手术患者围手术期管理中的安全性，并优化其使用。这项初步研究的结果为一项确定性随机对照试验奠定了基础，该试验可能有助于阐明围手术期ASA用药在接受择期手术患者中的使用情况及潜在风险/益处。

试验注册

该试验已在Current Controlled Trials注册，注册号为ISRCTN45810007。

相似文献

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

BMC Surg. 2011 Mar 3;11:7. doi: 10.1186/1471-2482-11-7.

A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

Langenbecks Arch Surg. 2012 Feb;397(2):297-306. doi: 10.1007/s00423-011-0867-7. Epub 2011 Nov 3.

Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Surg Endosc. 2016 Dec;30(12):5542-5549. doi: 10.1007/s00464-016-4926-6. Epub 2016 Apr 29.

The safe and risk assessment of perioperative antiplatelet and anticoagulation therapy in inguinal hernia repair, a systematic review.

Surg Endosc. 2019 Oct;33(10):3165-3176. doi: 10.1007/s00464-019-06956-y. Epub 2019 Jul 15.

Effects of Perioperative Acetyl Salicylic Acid on Clinical Outcomes in Patients Undergoing Craniotomy for Brain Tumor.

World Neurosurg. 2015 Jul;84(1):41-7. doi: 10.1016/j.wneu.2015.02.016. Epub 2015 Feb 26.

The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial.

Am J Surg. 2016 Jun;211(6):1019-25. doi: 10.1016/j.amjsurg.2015.05.036. Epub 2015 Aug 20.

Low-dose acetylsalicylic acid and bleeding risks with ventriculoperitoneal shunt placement.

Neurosurg Focus. 2016 Sep;41(3):E4. doi: 10.3171/2016.6.FOCUS16173.

Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery.

J Vasc Surg. 2011 Sep;54(3):779-84. doi: 10.1016/j.jvs.2011.03.003. Epub 2011 May 14.

Continuation of low-dose acetylsalicylic acid during perioperative period of laparoscopic inguinal hernia repair is safe: results of a prospective clinical trial.

Hernia. 2019 Dec;23(6):1141-1148. doi: 10.1007/s10029-019-02040-5. Epub 2019 Sep 5.

Safety of elective laparoscopic cholecystectomy in patients with antiplatelet therapy: Lessons from more than 800 operations in a single tertiary referral institution.

Asian J Endosc Surg. 2020 Jan;13(1):33-38. doi: 10.1111/ases.12693. Epub 2019 Feb 19.

引用本文的文献

Impact of antithrombotic agents on short-term outcomes following minimally invasive colorectal cancer surgery: a propensity score-matched analysis.

Int J Colorectal Dis. 2022 May;37(5):1049-1062. doi: 10.1007/s00384-022-04148-0. Epub 2022 Apr 11.

American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period.

J Can Assoc Gastroenterol. 2022 Mar 17;5(2):100-101. doi: 10.1093/jcag/gwac010. eCollection 2022 Apr.

Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.

Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD012584. doi: 10.1002/14651858.CD012584.pub2.

本文引用的文献

Perioperative handling of patients on antiplatelet therapy with need for surgery.

Intern Emerg Med. 2009 Aug;4(4):279-88. doi: 10.1007/s11739-009-0265-0. Epub 2009 Jun 16.

Antiplatelet agents in the perioperative period.

Arch Surg. 2009 Jan;144(1):69-76; discussion 76. doi: 10.1001/archsurg.144.1.69.

Management of surgical patients receiving anticoagulation and antiplatelet agents.

Br J Surg. 2008 Dec;95(12):1437-48. doi: 10.1002/bjs.6381.

[Surgical procedures in patients treated with platelet function inhibitors].

Herz. 2008 Jun;33(4):254-9. doi: 10.1007/s00059-008-3137-x.

Low-dose aspirin and clopidogrel: how to act in patients scheduled for day surgery.

Curr Opin Anaesthesiol. 2007 Dec;20(6):531-4. doi: 10.1097/ACO.0b013e3282f15f95.

[Perioperative therapy with antiplatelet agents].

Anaesthesist. 2007 Jun;56(6):592-8. doi: 10.1007/s00101-007-1187-8.

[Perioperative hemostasis management].

Chirurg. 2007 Jan;78(1):69-79; quiz 80-1. doi: 10.1007/s00104-006-1273-5.

Antiplatelet agents and perioperative bleeding.

Can J Anaesth. 2006 Jun;53(6 Suppl):S103-12. doi: 10.1007/BF03022257.

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis.

J Intern Med. 2005 May;257(5):399-414. doi: 10.1111/j.1365-2796.2005.01477.x.

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

一项评估并优化抗血小板药物在普通外科和腹部外科手术围手术期管理中使用的随机对照试验——APAP试验（国际标准随机对照试验编号：ISRCTN45810007）

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

作者信息

Antolovic Dalibor, Reissfelder Christoph, Rakow Anastasia, Contin Pietro, Rahbari Nuh N, Büchler Markus W, Weitz Jürgen, Koch Moritz

机构信息

Department of Surgery, University of Heidelberg, Germany.

出版信息

BMC Surg. 2011 Mar 3;11:7. doi: 10.1186/1471-2482-11-7.

DOI:10.1186/1471-2482-11-7

PMID:21371292

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3056734/

Abstract

BACKGROUND

DISCUSSION

TRIAL REGISTRATION

The trial is registered with Current Controlled Trials ISRCTN45810007.

摘要

背景

讨论

试验注册

该试验已在Current Controlled Trials注册，注册号为ISRCTN45810007。

一项评估并优化抗血小板药物在普通外科和腹部外科手术围手术期管理中使用的随机对照试验——APAP试验（国际标准随机对照试验编号：ISRCTN45810007）

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

作者信息

机构信息

出版信息

BACKGROUND

DISCUSSION

TRIAL REGISTRATION

背景

讨论

试验注册

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

一项评估并优化抗血小板药物在普通外科和腹部外科手术围手术期管理中使用的随机对照试验——APAP试验（国际标准随机对照试验编号：ISRCTN45810007）

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

作者信息

机构信息

出版信息

BACKGROUND

DISCUSSION

TRIAL REGISTRATION

背景

讨论

试验注册